Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
September 30, 2026 13.47B
June 30, 2026 10.96B
March 31, 2026 11.49B
December 31, 2025 12.34B
September 30, 2025 12.14B
June 30, 2025 12.01B
March 31, 2025 12.70B
December 31, 2024 14.14B
September 30, 2024 15.80B
June 30, 2024 15.68B
March 31, 2024 16.73B
December 31, 2023 18.43B
September 30, 2023 19.45B
June 30, 2023 21.88B
March 31, 2023 24.12B
December 31, 2022 26.09B
September 30, 2022 26.06B
June 30, 2022 26.04B
Date Value
March 31, 2022 27.61B
December 31, 2021 24.87B
September 30, 2021 20.92B
June 30, 2021 16.15B
March 31, 2021 12.69B
December 31, 2020 7.337B
September 30, 2020 4.651B
June 30, 2020 3.486B
March 31, 2020 2.068B
December 31, 2019 1.589B
September 30, 2019 1.591B
June 30, 2019 1.685B
March 31, 2019 1.806B
December 31, 2018 1.962B
September 30, 2018 1.489B
June 30, 2018
March 31, 2018
December 31, 2017 1.084B

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Revolution Medicines, Inc. 4.304B
Vaxcyte, Inc. 2.989B
Twist Bioscience Corp. --
BioNTech SE 22.91B
Vir Biotechnology, Inc. 1.112B

Total Assets (Quarterly) Related Metrics